Could Merck & Co., Inc. (MRK) and Gilead Sciences, Inc. (GILD)’s Partnership Create the Next Big Pharma Growth Engine
Two biopharma giants, Merck & Co., Inc. (NYSE:MRK) and Gilead Sciences, Inc.
Merck & Co. Inc. (MRK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Fisher Asset Management Ken Fisher | 38,516,263 | $4,949,339,962 | +46% | 1.47% |
| 2. | Harris Associates Natixis Global Asset Management | 12,073,109 | $1,551,394,499 | -3% | 2.06% |
| 3. | AQR Capital Management Cliff Asness | 8,134,262 | $1,039,396,005 | -6% | 0.36% |
| 4. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 3,966,523 | $509,698,206 | +36% | 0.23% |
| 5. | 3,756,900 | $482,761,650 | +1% | 0.06% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $88.25 | 2,833 | $249,999.98 | 2,933 | 2025-02-06 | Filing | |
| $88.50 | 15,000 | $1,327,500.00 | 16,000 | 2025-02-05 | Filing | |
| $113.68 | 3 | $341.04 | 20,599 | 2023-04-26 | Filing | |
| $105.47 | 136 | $14,343.92 | 20,631 | 2023-03-20 | Filing | |
| $109.20 | 11 | $1,201.20 | 20,495 | 2023-02-21 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $135.00 | 10,000 | $1,350,000.00 | 36,613 | 2026-08-13 | Filing | |
| $133.46 | 80,315 | $10,718,494.55 | 45,509 | 2026-08-12 | Filing | |
| $132.04 | 600 | $79,222.02 | 110,167 | 2026-08-12 | Filing | |
| $131.61 | 11,099 | $1,460,770.47 | 110,767 | 2026-08-12 | Filing | |
| $132.35 | 5,427 | $718,261.28 | 121,866 | 2026-08-11 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 226,999,837 | $29,169,479,139 | 0.43% | |
| 2. | 161,323,174 | $20,730,027,859 | 0.44% | |
| 3. | 120,413,256 | $15,573,753,504 | 0.46% | |
| 4. | 86,249,283 | $11,083,032,867 | 1.91% | |
| 5. | 67,738,969 | $8,704,457,517 | 0.39% |
News See All
3 Best ETFs to Invest In, According to the AI Analyst – 8/5/2026
Exchange-traded funds (ETFs) are a preferred investment choice, as they help investors mitigate risk through diversification at low costs. Moreover...
Options Volatility and Implied Earnings Moves Today, August 04, 2026
Today, several major companies are expected to report earnings: Advanced Micro Devices (AMD), Caterpillar (CAT), Energy Transfer (ET), Gilead Scien...
These Are the Stocks Reporting Earnings Today – August 4, 2026
Here’s a look at today’s most important earnings reports from major publicly traded companies. Investors will be watching closely for revenue and p...
Options Volatility and Implied Earnings Moves This Week, August 03 – August 06, 2026
This week, several major companies will be reporting earnings. Among them are Palantir Technologies (PLTR), Advanced Micro Devices (AMD), Walt Disn...
Moderna Wins a Post-COVID Earnings Beat as Analyst Eyes ‘Clinically Meaningful’ Trial Results
Moderna’s ($MRNA) latest earnings were better-than-expected. Jefferies ($JEF) analyst Andrew Tsai explained that while quarterly earnings beat expe...
SCHD vs. VYMI: Which Dividend ETF Comes Out on Top?
Dividend ETFs are one of the most popular ways to earn passive income, but choosing the right fund isn’t always easy. Among the leading options are...
Big Pharma Is Buying Growth. Novartis (NVS) Is Betting on Its Pipeline
Biotech M&A has hit a record pace in 2026, with deal value reaching $216 billion so far this year, up from $118 billion over the same stretch last year, according to LSEG data.
Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks
Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital Management, a quantitative hedge fund.
10 Reliable Dividend Stocks to Buy for Long-Term Investors
Dividend stocks have long been a favorite among investors focused on building wealth over time.
Hedge Fund Resource Center